Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED)

NCT00751179 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuromuscular Blockade

Interventions

DRUG: rocuronium
DRUG: sugammadex
DRUG: succinylcholine

Sponsor

Merck Sharp & Dohme LLC